AstraZeneca is a global biopharmaceutical company with several leading pharmaceutical products. As of 2021, AstraZeneca’s top pharmaceutical product by revenue was Tagrisso, a medication used in the treatment of non-small-cell lung carcinomas. During that year, Tagrisso generated five billion U.S. dollars in revenue for the company. The second-highest revenue generator for AstraZeneca in the same year was Vaxzevria, the COVID-19 vaccine. Vaxzevria generated about 3.9 billion U.S. dollars in revenue during that year.
AstraZeneca company profile
AstraZeneca is a global pharmaceutical company with many employees all over the world. As of 2020, the highest proportion of AstraZeneca’s employees were based in the Asia-Pacific region. The global office and corporate headquarters of AstraZeneca is located in Cambridge in the United Kingdom. As of 2021, emerging markets and the U.S. market accounted for the highest revenues for AstraZeneca. The company is a leader in research and development globally as well.
AstraZeneca’s R&D
AstraZeneca has many research and development programs that are focused on addressing three main areas, oncology, cardiovascular, renal and metabolic diseases, and respiratory disease. AstraZeneca’s research and development expenditures have increased in recent years. In 2021, almost 27 percent of AstraZeneca’s total revenue was expended on research and development. And, as of early 2021, AstraZeneca was projected to be among the world’s top 10 pharmaceutical companies according to the number of drugs they had under development at that time.
Top products of AstraZeneca based on revenue from 2019 to 2021
(in million U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
AstraZeneca. (February 21, 2022). Top products of AstraZeneca based on revenue from 2019 to 2021 (in million U.S. dollars) [Graph]. In Statista. Retrieved July 05, 2022, from https://www.statista.com/statistics/267807/astrazeneca-top-products-based-on-revenue/
AstraZeneca. "Top products of AstraZeneca based on revenue from 2019 to 2021 (in million U.S. dollars)." Chart. February 21, 2022. Statista. Accessed July 05, 2022. https://www.statista.com/statistics/267807/astrazeneca-top-products-based-on-revenue/
AstraZeneca. (2022). Top products of AstraZeneca based on revenue from 2019 to 2021 (in million U.S. dollars). Statista. Statista Inc.. Accessed: July 05, 2022. https://www.statista.com/statistics/267807/astrazeneca-top-products-based-on-revenue/
AstraZeneca. "Top Products of Astrazeneca Based on Revenue from 2019 to 2021 (in Million U.S. Dollars)." Statista, Statista Inc., 21 Feb 2022, https://www.statista.com/statistics/267807/astrazeneca-top-products-based-on-revenue/
AstraZeneca, Top products of AstraZeneca based on revenue from 2019 to 2021 (in million U.S. dollars) Statista, https://www.statista.com/statistics/267807/astrazeneca-top-products-based-on-revenue/ (last visited July 05, 2022)